Celularity CELU
NASDAQ CELU
$1.43 -0.01 (-0.35%)
At close: Sep 10, 2026 · 4:00 PM EDT

Celularity (CELU) Non-Current Assets (2018 - 2025)

Celularity's (CELU) quarterly Non-Current Assets came in at -$12.0 million in Q4 2025, down 110.69% year-over-year from $112.1 million in Q4 2024, and down 111.56% quarter-over-quarter from $103.6 million in Q3 2025.

Analysis

Celularity (CELU) Non-Current Assets (2018 - 2025) Analysis & Trends

Celularity (CELU) has reported Non-Current Assets for 8 consecutive years, with -$12.0 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 110.69% year-over-year to -$12.0 million in Q4 2025; TTM through Dec 2025 was $301.5 million, a 35.19% decrease from a year earlier, with the FY2025 full-year figure at -$12.0 million, down 110.69% from the prior year.
  • Non-Current Assets was -$12.0 million for Q4 2025 at Celularity, down from $103.6 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $374.0 million in Q3 2022 and troughed at -$12.0 million in Q4 2025.
  • A 5-year average of $209.2 million and a median of $134.5 million in 2021 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets soared 175.7% in 2022 and tumbled 110.69% in 2025, its largest moves.
  • Over 5 years, Non-Current Assets stood at $355.0 million in 2021, then rose by 3.53% to $367.6 million in 2022, then slumped by 66.24% to $124.1 million in 2023, then retreated by 9.65% to $112.1 million in 2024, then plunged by 110.69% to -$12.0 million in 2025.
  • The last three Non-Current Assets figures came in at -$12.0 million (Q4 2025), $103.6 million (Q3 2025), and $103.0 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 441.00 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 279.00 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 451.27 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 523.50 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 150.83 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 207.76 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 35.91 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 964.69 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 238.14 Mn
10 Celularity 36.35 Mn 30.17 Mn -3.27 Mn -11.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -11.98 Mn
Sep 30, 2025 103.64 Mn
Jun 30, 2025 103.02 Mn
Mar 31, 2025 106.80 Mn
Dec 31, 2024 112.12 Mn
Sep 30, 2024 114.34 Mn
Jun 30, 2024 117.76 Mn
Mar 31, 2024 120.96 Mn
Dec 31, 2023 124.10 Mn
Sep 30, 2023 140.69 Mn
Jun 30, 2023 228.38 Mn
Mar 31, 2023 337.41 Mn
Dec 31, 2022 367.56 Mn
Sep 30, 2022 374.02 Mn
Jun 30, 2022 353.88 Mn
Mar 31, 2022 358.46 Mn
Dec 31, 2021 355.03 Mn
Sep 30, 2021 357.01 Mn
Jun 30, 2021 128.36 Mn
Mar 31, 2021 291.83 Mn